November 2023 Medical News Summary episode artwork

EPISODE · Nov 30, 2023 · 12 MIN

November 2023 Medical News Summary

from JAMA Medical News

Why Physicians Don't Deprescribe Medicines; What to Know About Wegovy's Rare but Serious Adverse Effects; What to Know About Zepbound, the Newest Antiobesity Drug Related Content: As Semaglutide's Popularity Soars, Rare but Serious Adverse Effects Are Emerging FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management Deciding When It's Better to Deprescribe Medicines Than to Continue Them

NOW PLAYING

November 2023 Medical News Summary

0:00 12:18

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of JAMA Medical News?

This episode is 12 minutes long.

When was this JAMA Medical News episode published?

This episode was published on November 30, 2023.

What is this episode about?

Why Physicians Don't Deprescribe Medicines; What to Know About Wegovy's Rare but Serious Adverse Effects; What to Know About Zepbound, the Newest Antiobesity Drug Related Content: As Semaglutide's Popularity Soars, Rare but Serious Adverse Effects...

Can I download this JAMA Medical News episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!